360 related articles for article (PubMed ID: 34624198)
21. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
22. The evolving epidemiology of hepatocellular carcinoma: a global perspective.
Wallace MC; Preen D; Jeffrey GP; Adams LA
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):765-79. PubMed ID: 25827821
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.
Pocha C; Kolly P; Dufour JF
Semin Liver Dis; 2015 Aug; 35(3):304-17. PubMed ID: 26378646
[TBL] [Abstract][Full Text] [Related]
25. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.
Ford MM; Ivanina E; Desai P; Highfield L; Qiao B; Schymura MJ; Laraque F
Cancer Causes Control; 2017 Jul; 28(7):779-789. PubMed ID: 28573469
[TBL] [Abstract][Full Text] [Related]
26. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
27. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
Khan G; Hashim MJ
Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
[TBL] [Abstract][Full Text] [Related]
28. Global trends and predictions in hepatocellular carcinoma mortality.
Bertuccio P; Turati F; Carioli G; Rodriguez T; La Vecchia C; Malvezzi M; Negri E
J Hepatol; 2017 Aug; 67(2):302-309. PubMed ID: 28336466
[TBL] [Abstract][Full Text] [Related]
29. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.
Mittal S; Sada YH; El-Serag HB; Kanwal F; Duan Z; Temple S; May SB; Kramer JR; Richardson PA; Davila JA
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):594-601.e1. PubMed ID: 25148760
[TBL] [Abstract][Full Text] [Related]
30. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
Loomba R; Lim JK; Patton H; El-Serag HB
Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.
Zhu RX; Seto WK; Lai CL; Yuen MF
Gut Liver; 2016 May; 10(3):332-9. PubMed ID: 27114433
[TBL] [Abstract][Full Text] [Related]
32. Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies.
Turcanu A; Pitel E; Dumbrava VT; Tcaciuc E; Donscaia A; Peltec A; Pineau P
Rom J Intern Med; 2019 Mar; 57(1):37-46. PubMed ID: 30375353
[TBL] [Abstract][Full Text] [Related]
33. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
34. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
35. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma.
Lampimukhi M; Qassim T; Venu R; Pakhala N; Mylavarapu S; Perera T; Sathar BS; Nair A
Cureus; 2023 Nov; 15(11):e49429. PubMed ID: 38149129
[TBL] [Abstract][Full Text] [Related]
36. Changing epidemiology of hepatocellular carcinoma in Asia.
Zhang CH; Cheng Y; Zhang S; Fan J; Gao Q
Liver Int; 2022 Aug; 42(9):2029-2041. PubMed ID: 35319165
[TBL] [Abstract][Full Text] [Related]
37. Battlefield against hepatitis B infection and HCC in Africa.
Lemoine M; Thursz MR
J Hepatol; 2017 Mar; 66(3):645-654. PubMed ID: 27771453
[TBL] [Abstract][Full Text] [Related]
38. Viral hepatitis B and hepatocellular carcinoma.
Michielsen P; Ho E
Acta Gastroenterol Belg; 2011 Mar; 74(1):4-8. PubMed ID: 21563647
[TBL] [Abstract][Full Text] [Related]
39. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
40. Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications.
Tran NH
Curr Oncol Rep; 2022 Feb; 24(2):187-193. PubMed ID: 35061189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
